Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography

International Urology and Nephrology

Volumn 44, Issue 4, 2012, Pages 1161-1168

  Davoodi, Gholamreza ^a   Pari, Samira Mehrabi ^a   Rezvanfard, Mehrnaz ^a   Fathollahi, Mahmood Sheikh ^a   Amini, Manouchehr ^b   Hakki, Elham ^b   Kazemisaeid, Ali ^a   Yaminisharif, Ahmad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary angiography; Coronary artery disease (CAD); Glomerular filtration rate (GFR); Renal insufficiency

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PREDICTION; RETROSPECTIVE STUDY; SMOKING HABIT;

AGED; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84867902026     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-011-0070-3     Document Type: Article

References (44)

1. Sarnak MJ, Coronado BE, Greene T, Wang SR, Kusek JW, Beck GJ et al (2002) Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol 57:327-335
2. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG et al (1989) Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results: from the hypertension detection and follow- up program. The Hypertension detection and follow-up program cooperative group. Hypertension 13:I80-I193
3. Solak Y, Akilli H, Atalay H, Kayrak M, Gok H, Turk S (2010) The association of glomerular filtration rate and erectile dysfunction with severity of coronary artery disease in patients presenting with chest pain. Int Urol Nephrol 42:765-771
4. Muntner P, He J, Hamm L, Loria C, Whelton PK (2002) Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13:745-753
5. Beddhu S, Allen-Brady K, Cheung AK, Horne BD, Bair T, Muhlestein JB et al (2002) Impact of renal failure on the risk of myocardial infarction and death. Kidney Int 62: 1776-1783
6. Henry RMA, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ et al (2002) Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int 62:1402-1407
7. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Eng J Med 351: 1296-1305
8. Manjunath G, Tighiouart H, Coresh J, Macleod B, Salem DN, Griffith JL et al (2003) Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 63:1121-1129
9. Mann JFE, Gerstein HC, Pogue J, Bosch J, Yusuf S (2001) Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134:629-636
10. Best PJM, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR Jr et al (2002) The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39:1113-1119
11. Wison S, Foo K, Cunningham J, Cooper J, Deaner A, Knight C et al (2003) Renal function and risk stratification in acute coronary syndromes. Am J Cardiol 91:1051-1054
12. Jungers P, Massy ZA, Nguyen Khoa T, Fumeron C, Labrunie M, Lacour B et al (1997) Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 12:2597-2602
13. Reis SE, Olson MB, Fried L, Reeser V, Mankad S, Pepine CJ et al (2002) Mild renal insufficiency is associated with angiographic coronary artery disease in women. Circulation 105:2826-2829
14. Khalique O, Aronow WS, Ahn C, Mazar M, Schair B, Shao J et al (2007) Relation of moderate or severe reduction in glomerular filtration rate to number of coronary arteries narrowed[50% in patients undergoing coronary angiography for suspected coronary artery disease. Am J Cardiol 100:415-416
15. GargAX,ClarkWF,HaynesRB,HouseAA(2002)Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int 61:1486-1494
16. Culleton BF, Larson MG, Wilson PWF, Evans JC, Parfrey PS, Levy D (1999) Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56:2214-2219
17. Brancati FL, Whelton P, Randali B (1997) Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRIIF. Multiple risk factor intervention trial. JAMA 278:2069-2074
18. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE et al (1996) Blood pressure and end-stage renal disease in men. N Engl J Med 334:13-18
19. Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA et al (1999) ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 33:1756-1824
20. CirilloM(2010) Evaluation of glomerular filtration rate and of albuminuria/proteinuria. J Nephrol 23:125-132
21. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604-612
22. Eknoyan G, Levin NW, K/DOQI (2002) Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:1-266
23. American College of Cardiology National Cardiovascular Data Registry, Cardiac Catheterization Module 3.04 DDA, http://www.ncdr.com/WebNCDR/ NCDRDocuments/a.datadictdefsonlyv30.pdf. Accessed Dec 1
24. Agresti A (2002) Categorical Data Analysis. John Wiley & Sons, Boston
25. Sarnak MJ, Levey AS (2000) Cardiovascular disease, chronic renal disease: a new paradigm. Am J Kidney Dis 35:117-131
26. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP et al (2003) Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107:87-92
27. Knight EL, Rimm EB, Pai JK, Rexrode KM, Cannuscio CC, Manson JAE et al (2004) Kidney dysfunction, inflammation, and coronary events: a prospective study. J Am Soc Nephrol 15:1897-1903
28. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-658
29. Zebrack JS, Anderson JL, Beddhu S, Horne BD, Bair TL, Cheung A et al (2003) Do associations with C-Reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency? J Am Coll Cardiol 42:57-63
30. Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ (2006) Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 151:492-500
31. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112: 2627-2633
32. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D et al (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483
33. Lishmanov A, Dorairajan S, Pak Y, Chaudhary K, Chockalingam A (2011) Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease. Int Urol Nephrol 43:161-173
34. Koenig W, Twardella D, Brenner H, Rothenbacher D (2005) Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 51:321-327
35. Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S (1999) Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Internal Med 131:363-375
36. Bostom AG, Lathrop L (1997) Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 52: 10-20
37. Anderson JL, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, Madsen TE et al (2000) Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation 102:1227-1232
38. Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 283:2404-2410
39. Gesquière L, Loreau N, Minnich A, Davignon J, Blache D (1999) Oxidative stress leads to cholesterol accumulation in vascular smooth muscle cells. Free Radic Biol Med 27: 134-145
40. Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG (1999) Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocysteinemia in humans. Circulation 100:1161-1168
41. Koch M, Kutkuhn B, Trenkwalder E, Bach D, Grabensee B, Dieplinger H et al (1997) Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein (a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol 8:1889-1898
42. Muntner P, He J, Astor BC, Folsom AR, Coresh J (2005) Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol 16:529-538
43. Romanic AM, Arleth AJ, Willette RN, Ohlstein EH (1998) Factor XIIIa cross-links lipoprotein (a) with fibrinogen and is present in human atherosclerotic lesions. Circ Res 83: 264-269
44. Sechi LA, Zingaro L, Catena C, De Marchi S (2000) Increased fibrinogen levels and hemostatic abnormalities in patients with arteriolar nephrosclerosis: association with cardiovascular events. J Thromb Haemost 84:565-570